Primary Site >> Liver Cancer

Gene >> CD274

Journal: J Huazhong Univ Sci Technolog Med Sci. 2004;24(6):531-4.
Title: Investigation on the effects of soluble programmed death-1 (sPD-1) enhancing anti-tumor immune response.
Author: Yuan, Ye|He, Yufei|Wang, Xiaohong|Zhang, Hui|Li, Dong|Feng, Zuohua|Zhang, Guimei
PMID: 15791831
Journal: Int J Cancer. 2011 Dec 1;129(11):2651-61.
Title: Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
Author: Zhao, Wenxiu|Zhang, Lei|Yin, Zhenyu|Su, Weixue|Ren, Guangli|Zhou, Changsheng|You, Junyong|Fan, Jia|Wang, Xiaomin
PMID: 21213212
Journal: PLoS One. 2012;7(3):e32493.
Title: Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma.
Author: Cariani, Elisabetta|Pilli, Massimo|Zerbini, Alessandro|Rota, Cristina|Olivani, Andrea|Pelosi, Guido|Schianchi, Claudia|Soliani, Paolo|Campanini, Nicoletta|Silini, Enrico Maria|Trenti, Tommaso|Ferrari, Carlo|Missale, Gabriele
PMID: 22396772
Journal: PLoS One. 2015 Jun 26;10(6):e0131403.
Title: PD-L1 and Survival in Solid Tumors: A Meta-Analysis.
Author: Wu, Pin|Wu, Dang|Li, Lijun|Chai, Ying|Huang, Jian
PMID: 26114883
Journal: J Surg Oncol. 2016 Jan;113(1):55-61.
Title: Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.
Author: Ang, Celina|Miura, John T|Gamblin, T Clark|He, Ruth|Xiu, Joanne|Millis, Sherri Z|Gatalica, Zoran|Reddy, Sandeep K|Yee, Nelson S|Abou-Alfa, Ghassan K
PMID: 26661118
Journal: J Hepatol. 2016 Nov;65(5):944-952.
Title: CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation.
Author: Li, Chang Xian|Ling, Chang Chun|Shao, Yan|Xu, Aimin|Li, Xiang Cheng|Ng, Kevin Tak-Pan|Liu, Xiao Bing|Ma, Yuen Yuen|Qi, Xiang|Liu, Hui|Liu, Jiang|Yeung, Oscar Wai Ho|Yang, Xin Xiang|Liu, Qing Sheng|Lam, Yin Fan|Zhai, Yuan|Lo, Chung Mau|Man, Kwan
PMID: 27245433
Journal: Onco Targets Ther. 2016 Aug 12;9:5023-39.
Title: PD-L1 expression in human cancers and its association with clinical outcomes.
Author: Wang, Xin|Teng, Feifei|Kong, Li|Yu, Jinming
PMID: 27574444
Journal: Oncoimmunology. 2016 Sep 20;5(11):e1234565.
Title: Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma.
Author: Lacotte, Stephanie|Slits, Florence|Orci, Lorenzo A|Meyer, Jeremy|Oldani, Graziano|Delaune, Vaihere|Gonelle-Gispert, Carmen|Morel, Philippe|Toso, Christian
PMID: 27999748
Journal: Gastroenterology. 2017 Sep;153(3):812-826.
Title: Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
Author: Sia, Daniela|Jiao, Yang|Martinez-Quetglas, Iris|Kuchuk, Olga|Villacorta-Martin, Carlos|Castro de Moura, Manuel|Putra, Juan|Camprecios, Genis|Bassaganyas, Laia|Akers, Nicholas|Losic, Bojan|Waxman, Samuel|Thung, Swan N|Mazzaferro, Vincenzo|Esteller, Manel|F
PMID: 28624577
Journal: Gastroenterology. 2017 Oct;153(4):1107-1119.e10.
Title: Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Author: Zhou, Guoying|Sprengers, Dave|Boor, Patrick P C|Doukas, Michail|Schutz, Hannah|Mancham, Shanta|Pedroza-Gonzalez, Alexander|Polak, Wojciech G|de Jonge, Jeroen|Gaspersz, Marcia|Dong, Haidong|Thielemans, Kris|Pan, Qiuwei|IJzermans, Jan N M|Bruno, Marco J|Kwe
PMID: 28648905
Journal: Oncol Rep. 2017 Aug;38(2):899-907.
Title: Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma.
Author: Liu, Jianhua|Liu, Yahui|Meng, Lingyu|Liu, Kai|Ji, Bai
PMID: 28627705
Journal: Medicine (Baltimore). 2017 May;96(18):e6369.
Title: Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.
Author: Wang, Qianqian|Liu, Fang|Liu, Lei
PMID: 28471952
Journal: Gastroenterology. 2017 Jul;153(1):249-262.e2.
Title: Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
Author: Zhang, Weilong|He, Huan|Zang, Mengya|Wu, Qifeng|Zhao, Hong|Lu, Ling-Ling|Ma, Peiqing|Zheng, Hongwei|Wang, Nengjin|Zhang, Ying|He, Siyuan|Chen, Xiaoyan|Wu, Zhiyuan|Wang, Xiaoyue|Cai, Jianqiang|Liu, Zhihua|Sun, Zongtang|Zeng, Yi-Xin|Qu, Chunfeng|Jiao, Yuche
PMID: 28363643
Journal: Cell Death Dis. 2018 Apr 1;9(4):422.
Title: Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma.
Author: Cheng, Yusheng|Li, Hui|Deng, Yinan|Tai, Yan|Zeng, Kaining|Zhang, Yingcai|Liu, Wei|Zhang, Qi|Yang, Yang
PMID: 29556041
Journal: Nat Commun. 2018 Mar 28;9(1):1241.
Title: Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion.
Author: Sun, Cheng|Lan, Peixiang|Han, Qiuju|Huang, Mei|Zhang, Zhihong|Xu, Geliang|Song, Jiaxi|Wang, Jinyu|Wei, Haiming|Zhang, Jian|Sun, Rui|Zhang, Cai|Tian, Zhigang
PMID: 29593314
Journal: Biomedicines. 2018 Apr 6;6(2). pii: biomedicines6020041.
Title: Transcriptome Analysis of Acute Phase Liver Graft Injury in Liver Transplantation.
Author: Lee, Nikki P|Wu, Haiyang|Ng, Kevin T P|Luo, Ruibang|Lam, Tak-Wah|Lo, Chung-Mau|Man, Kwan
PMID: 29642405
Journal: Gastroenterology. 2018 Aug 23. pii: S0016-5085(18)34897-2.
Title: Association Between Expression Level of PD1 by Tumor-Infiltrating CD8(+) T Cells and Features of Hepatocellular Carcinoma.
Author: Kim, Hyung-Don|Song, Gi-Won|Park, Seongyeol|Jung, Min Kyung|Kim, Min Hwan|Kang, Hyo Jeong|Yoo, Changhoon|Yi, Kijong|Kim, Kyung Hwan|Eo, Sukyeong|Moon, Deok-Bog|Hong, Seung-Mo|Ju, Young Seok|Shin, Eui-Cheol|Hwang, Shin|Park, Su-Hyung
PMID: 30145359
Journal: Clin Exp Pharmacol Physiol. 2018 Aug 30.
Title: The roles of PD-1/PD-L1 and its signalling pathway in gastrointestinal tract cancers.
Author: Cui, Chunguo|Yu, Bo|Jiang, Qi|Li, Xingfang|Shi, Kaiyao|Yang, Zecheng
PMID: 30161295
Journal: Crit Rev Oncol Hematol. 2018 Oct;130:13-26.
Title: Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists.
Author: Stein, Alexander|Markus, Moehler|Jorg, Trojan|Eray, Goekkurt|Vogel, Arndt
PMID: 30196908
Journal: Clin Transl Oncol. 2018 Nov 1. pii: 10.1007/s12094-018-1975-4.
Title: Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives.
Author: Mocan, T|Sparchez, Z|Craciun, R|Bora, C N|Leucuta, D C
PMID: 30387047